Work

Phase 1 Results of Anti-PD-Ligand 1 (Durvalumab) & Lenalidomide in Patients with Cutaneous T Cell Lymphoma and Correlation with Programmed Death Ligand 1 Expression and Gene Expression Profile

Year: 2020

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2020-143354

Authors: Christiane Querfeld, Ni-Chun Tsai, Joycelynne Palmer, Xochiquetzal U. Martinez, Farah Abdulla, Xiwei Wu, Steven T. Rosen, Jasmine Zain

Institutions: City Of Hope National Medical Center, City of Hope, Beckman Research Institute

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4236383479

Cites:

Cited by: 6

Related to: 10